Details for New Drug Application (NDA): 021489
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
The generic ingredient in PROHANCE MULTIPACK is gadoteridol. One supplier is listed for this compound. Additional details are available on the gadoteridol profile page.
Summary for 021489
Tradename: | PROHANCE MULTIPACK |
Applicant: | Bracco |
Ingredient: | gadoteridol |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 021489
Mechanism of Action | Magnetic Resonance Contrast Activity |
Suppliers and Packaging for NDA: 021489
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489 | NDA | Bracco Diagnostics Inc | 0270-1111 | 0270-1111-01 | 5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-01) / 10 mL in 1 VIAL, SINGLE-DOSE |
PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489 | NDA | Bracco Diagnostics Inc | 0270-1111 | 0270-1111-02 | 5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-02) / 15 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 279.3MG/ML | ||||
Approval Date: | Oct 9, 2003 | TE: | RLD: | Yes |
Expired US Patents for NDA 021489
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489-001 | Oct 9, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Bracco | PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489-001 | Oct 9, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Bracco | PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489-001 | Oct 9, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription